Takeshi Horai

Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer

Masahiro Fukuoka, Seiji Yano, Giuseppe Giaccone et al. · Journal of Clinical Oncology · 2003 · 2.9K citations

Medicine, Oncology, Pharmacology +13

LUX-Lung 4: A Phase II Trial of Afatinib in Patients With Advanced Non–Small-Cell Lung Cancer Who Progressed During Prior Treatment With Erlotinib, Gefitinib, or Both

Nobuyuki Katakami, Shinji Atagi, Kōichi Goto et al. · Journal of Clinical Oncology · 2013 · 324 citations · Full text

Medicine, Oncology, Pharmacology +15

A prospective phase II study on photodynamic therapy with photofrin II for centrally located early-stage lung cancer. The Japan Lung Cancer Photodynamic Therapy Study Group.

Kiyoyuki Furuse, M. Fukuoka, H. Kato et al. · Journal of Clinical Oncology · 1993 · 284 citations

Medicine, Oncology, Pharmacology +10

Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancer

Seiji Niho, Hideo Kunitoh, Hiroshi Nokihara et al. · Lung Cancer · 2012 · 214 citations · Full text

Medicine, Oncology, Pharmacology +12

Induction of in Vitro Tumor Cell Invasion of Cellular Monolayers by Lysophosphatidic Acid or Phospholipase D

Fumio Imamura, Takeshi Horai, Mutsuko Mukai et al. · Biochemical and Biophysical Research Communications · 1993 · 183 citations

Life Sciences, Cell Biology, Oncology +12